Skip to main content
AMH (Anti-Müllerian Hormone) · Normal: 0.5–6 ng/mL · Optimal: 1–3.5 ng/mL

What Is AMH (Anti-Müllerian Hormone)? Normal vs Optimal Range Explained

Anti-Müllerian hormone (AMH) is produced by small ovarian follicles and reflects your remaining egg supply—your ovarian reserve. Labs use a range of 0.5–6 ng/mL, but optimal AMH falls between 1 and 3.5 ng/mL. Below 1.0 at any age before 40 indicates diminished ovarian reserve, while values above 5.0 in young women may signal polycystic ovary syndrome (PCOS).

Want to check YOUR levels? Upload labs freeFree, 10 seconds →

Data sourced from PubMed, CTD. How we verify this data →
Sources verified as of April 2026
[01]

Normal vs Optimal Range

Lab Normal Range: 0.56 ng/mL
Optimal: 13.5 ng/mL
0.5 ng/mL6 ng/mL
Lab NormalOptimal

Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.

Range TypeLowHighUnit
Lab Normal0.56ng/mL
Optimal13.5ng/mL
[02]

Why Optimal Matters

The lab reference range of 0.5–6 ng/mL spans an enormous spectrum of reproductive potential, from a woman nearing menopause with a dwindling follicle pool to one with an abundance of small antral follicles suggestive of PCOS. This width makes it almost useless without age context. A woman is born with approximately one to two million oocytes, and that number declines irreversibly throughout life—by puberty roughly 300,000–400,000 remain, and AMH tracks this decline in real time. The CTD documents the AMH signaling pathway with 9 gene members involved in follicular regulation, but what matters clinically is simpler: AMH below 1.0 ng/mL at any age before 40 signals that the ovarian follicle pool is depleting faster than expected, meaning fewer years of fertility remain. Unlike FSH and estradiol, AMH does not fluctuate across the menstrual cycle—it can be drawn on any day, making it the most practical and stable single marker of ovarian reserve available.

PubMed indexes over 12,000 clinical publications on AMH, with fertility medicine driving most of the research. In IVF settings, AMH is the strongest predictor of how many eggs a stimulation cycle will retrieve—high AMH predicts robust response, while low AMH predicts poor response requiring adjusted protocols. But AMH measures quantity, not quality: a woman with an AMH of 0.5 ng/mL can still conceive naturally because she only needs one viable egg. The distinction matters emotionally and clinically. Where AMH becomes most actionable is in reproductive planning—a 30-year-old with AMH below 1.0 has a meaningfully shorter fertility window and may benefit from egg freezing or accelerated family planning.

On the upper end, AMH above 5.0 ng/mL in a young woman—particularly when paired with irregular periods and elevated androgens—raises concern for PCOS, in which the ovaries contain an excess of small antral follicles that each produce AMH. Elevated AMH in PCOS is not a sign of superior fertility; the excess follicles often fail to mature properly, leading to anovulation and difficulty conceiving without treatment. The optimal range of 1.0–3.5 ng/mL represents a balanced ovarian reserve: enough follicles to support regular ovulation and reasonable IVF response, without the hormonal dysregulation associated with excessively high follicle counts. Age-adjusted interpretation is always essential—an AMH of 1.5 at age 25 warrants concern, while the same value at 40 is entirely expected.

Want to see where YOUR levels fall?

Upload labs free — instant results →
[03]

Symptoms When Low

No direct symptoms—AMH reflects egg quantity, not hormones you feel day to dayShorter menstrual cycles (25 days or less) as ovarian reserve declinesDifficulty conceiving after six months of unprotected intercoursePoor response to IVF stimulation medications (fewer eggs retrieved)Earlier-than-expected perimenopause symptoms (hot flashes, night sweats before age 45)
[04]

Symptoms When High

No direct symptoms from high AMH itselfIrregular or absent menstrual periods (in context of PCOS)Acne along the jawline and chin (from PCOS-associated androgen excess)Excess facial or body hair growth (hirsutism)Difficulty conceiving due to anovulation despite having many follicles
[05]

What Affects This Marker

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD). AMH signaling pathway mapped with 9 gene members. North Carolina State University, 2025.
  2. [2]PubMed. Over 12,000 clinical publications on anti-Müllerian hormone in reproductive medicine. National Library of Medicine.
  3. [3]Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation. Fertility and Sterility. 2011;95(5):1تب-1770. PMID: 21183174.
  4. [4]Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Human Reproduction Update. 2014;20(3):370-385. PMID: 24430863.
  5. [5]La Marca A, Sighinolfi G, Radi D, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology. Human Reproduction Update. 2010;16(2):113-130. PMID: 19793843.
  6. [6]Tal R, Seifer DB. Ovarian reserve testing: a user's guide. American Journal of Obstetrics and Gynecology. 2017;217(2):129-140. PMID: 28235465.
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Upload Your Lab Results

See where your levels fall on the optimal scale.

Upload Labs Free →